The company will initially receive shares equal to about 80% of the total number expected to be repurchased. It plans to fund the transaction with existing cash and cash equivalents.
The final number of shares will depend on iRhythm’s volume-weighted average stock price during the buyback period. Final settlement is expected no later than the first quarter of 2027. After the transaction is completed, about $100 million will remain in the company’s repurchase authorization.

Comments (0)
No comments yet. Be the first!